FOLD Q4 2018 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$33M+121.6% YoY

Gross Profit

$28M86.7% margin

Operating Income

-$69M-212.9% margin

Net Income

-$78M-239.2% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+58.5%

Cash Flow

Operating Cash Flow

-$61M

Free Cash Flow

-$62M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$790M

Total Liabilities

$447M

Stockholders' Equity

$343M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$15M	+121.6%
Gross Profit	$28M	$12M	+133.5%
Operating Income	-$69M	-$68M	-2.7%
Net Income	-$78M	-$69M	-12.8%